Start
Features
Free trial / FAQ

Researchers
Physicians
Pharmacists
Ecotrophologists
Product Managers
in Health Industries

Loading…

Medical Research Finder

Legal Notice
Privacy
Terms of Use

meRfi® Microbiome - The Digital Gut Microbiome Reference (incl. AI Chat)
Prebiotics, Probiotics, FMT / Manipulators of the Intestinal Microbiota

AuthorsReferences (Sources)

meRfi® AI Chat

Liver Fibrosis / Cirrhosis & Hepatocellular Carcinoma (HCC)

Welcome to meRfi Microbiome!

Please register to continue your trial period!

meRfi Microbiome provides you with up-to-date, evidence-based insights on the gut microbiota and related health topics.

Access our ever-expanding digital library and get personalized answers through our interactive AI chat platform.

Start your free trial and transform your understanding of the gut microbiota today!

(Login)

Navigation

Cirrhosis of any etiology is a significant risk factor, although HCC can develop in its absence in patients with hepatitis B and increasingly in those with nonalcoholic fatty liver disease.
Ayoub et al. 2022 Expert Opinion on Emerging Drugs 27(2): 141-149

References (Sources)

Cirrhosis: A Questioned Risk Factor for Hepatocellular Carcinoma
Garrido & Djouder 2021 Trends in Cancer 7: 29
Review

AI Chat

7/1/2026

Chat with our artificial intelligence:

Start chat!

Liver Fibrosis / Cirrhosis & Hepatocellular Carcinoma (HCC)

Welcome to meRfi Microbiome!

Navigation

Contents

References (Sources)

AI Chat